(Q37964756)

26 August 2017

title

Pimecrolimus 1% cream for the treatment of seborrheic dermatitis: a systematic review of randomized controlled trials (English)

1 reference

26 August 2017

1 reference

Charlene U Ang-Tiu

1

1 reference

26 August 2017

Chandra F Meghrajani

series ordinal

2

1 reference

26 August 2017

Clarita C Maano

series ordinal

3

1 reference

26 August 2017

language of work or name

English

0 references

publication date

1 January 2012

1 reference

Expert Review of Clinical Pharmacology

26 August 2017

published in

1 reference

26 August 2017

volume

5

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

91-97

1 reference

26 August 2017

cites work

Pimecrolimus: a review.

1 reference

Etiology and management of Seborrheic dermatitis

21 January 2018

1 reference

Role of topical calcineurin inhibitors in the treatment of seborrheic dermatitis: a review of pathophysiology, safety, and efficacy

21 January 2018

1 reference

Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents

21 January 2018

1 reference

The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis

21 January 2018

1 reference

Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus

21 January 2018

1 reference

A new calcineurin inhibitor, pimecrolimus, inhibits the growth of Malassezia spp

21 January 2018

1 reference

Pilot trial of 1% pimecrolimus cream in the treatment of seborrheic dermatitis in African American adults with associated hypopigmentation

21 January 2018

1 reference

An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis

21 January 2018

1 reference

Treatment of facial seborrheic dermatitis with pimecrolimus cream 1%: an open-label clinical study in Korean patients

21 January 2018

1 reference

Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ECP.11.68

1 reference

26 August 2017

1 reference